Treatment with BDNF promoted cell invasion of diverse cancer cells [10–14], whereas suppression of BDNF/TrkB signaling abrogated invasion of hepatocellular carcinoma cells [15], migration and invasion of head and neck squamous cell carcinoma [13], as well as transitional cell carcinoma [16]. Here, NTRK2 is linked to cancer.